29 Oct 2009 15:00
ViaLogy plc ("the Company")
Grant of options
London, October 29, 2009. ViaLogy (LSE: VIY) The remuneration committee has today granted to certain directors options over, in aggregate, 5,877,712 ordinary shares, exerciseable at 5p per share.
| Director | Options granted | |
| Terry Bond, Chairman | 1,275,000 | |
| Robert Dean, CEO | 2,345,331 | |
| Dr Sandeep Gulati, CTO | 2,257,381 |
All the options are dependent on the Company meeting certain performance criteria for the financial year ended 31 March 2010 and are therefore subject to cancellation if those performance criteria are not met in full.
All of the options granted to Directors will be exerciseable for a period of seven years from 1 April 2010.
In addition, the remuneration committee has today granted to certain key employees options over, in aggregate, 2,142,069 ordinary shares, will be exerciseable at 5p per share. All of these options granted are dependent on the Company meeting certain performance criteria for the financial year ended 31 March 2010 and are therefore subject to cancellation if those performance criteria are not met in full.
All of the options granted to key employees will exerciseable for a period of seven years from 1 April 2010.
The remuneration committee has also agreed to immediately grant 2,704,000 options, exerciseable at 5p for a period of seven years from 24 October 2010 years, to Dr. Sandeep Gulati in recognition of his outstanding contribution to the development of ViaLogy's patented QuantumRD technology.
Enquiries:
| ViaLogy | 01235 834734 | |
| Terry Bond, Chairman | ||
| Seymour Pierce Limited | 020 7107 8000 | |
| Mark Percy |